BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Clinical trials for BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) trials appear
Sign up with your email to follow new studies for BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could 2 years of hormone therapy be enough for some breast cancers?
Disease control Not yet recruitingThis study looks at whether women with a common, early-stage breast cancer can safely take hormone-blocking pills for only 2 to 3 years instead of the usual 5 years. About 2,900 participants will be randomly assigned to either the shorter or standard treatment. The goal is to see…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
Radioactive seeds may boost breast cancer treatment response
Disease control Not yet recruitingThis study tests whether placing tiny radioactive seeds in breast tumors before chemotherapy can help the cancer disappear completely by the time of surgery. About 194 women with early-stage breast cancer will be randomly assigned to get seeds or standard care. The goal is to see…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: PHASE3 • Sponsor: Pengfei Qiu • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Freezing breast cancer: new study tests Needle-Freeze treatment for seniors
Disease control Not yet recruitingThis study tests a freezing technique called cryoablation as a main treatment for early-stage breast cancer in people aged 70 and older. Instead of surgery or long-term hormone pills, a needle is inserted through the skin to freeze and destroy the tumor. Researchers want to see i…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: NA • Sponsor: St. Antonius Hospital • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
New program aims to protect cancer Patients' hearts during treatment
Disease control Not yet recruitingThis study tests a program called Primary Care Connect (PC2) for cancer survivors who also have heart-related conditions like high blood pressure, diabetes, or high cholesterol. The goal is to see if the program helps them stay connected to their primary care doctor and better ma…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New drug combo aims to boost breast cancer remission before surgery
Disease control Not yet recruitingThis study tests whether adding the immunotherapy drug adebrelimab and/or the targeted drug SHR-A1811 to standard chemotherapy can help more people with HR-positive, HER2-low early breast cancer achieve a complete response (no cancer found at surgery). About 249 participants will…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
New scanner could slash repeat breast surgeries by spotting cancer cells in real time
Diagnosis Not yet recruitingThis study tests a new handheld scanner that helps surgeons see cancer cells at the edges of removed breast tissue during surgery. Current methods can miss some cancer, leading to repeat operations. The scanner gives results in under five minutes. About 165 women with early-stage…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Sponsor: West China Hospital • Aim: Diagnosis
Last updated Apr 30, 2026 15:48 UTC
-
Pill bottle meets fitbit: new study aims to boost med adherence in breast cancer survivors
Symptom relief Not yet recruitingThis study tests whether a system combining a smartphone app, a special pill bottle (Wisepill), and a Fitbit can help breast cancer survivors take their daily hormone therapy consistently. Fifteen survivors aged 21-70 will use the system for six months and share their experiences…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: NA • Sponsor: San Diego State University • Aim: Symptom relief
Last updated May 26, 2026 04:19 UTC
-
One and done? new breast cancer radiation trial could cut treatment time
Symptom relief Not yet recruitingThis study tests whether a single radiation treatment after breast cancer surgery works as well as the usual five treatments. It aims to make care easier for patients who live far from cancer centers. The trial will enroll 60 women aged 40 or older with early-stage breast cancer.
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Symptom relief
Last updated May 26, 2026 03:57 UTC
-
New study aims to protect older breast cancer patients from hidden drug risks
Knowledge-focused Not yet recruitingThis study follows 200 breast cancer patients aged 70 and older who are starting a combination of CDK4/6 inhibitors and hormone therapy after surgery. Researchers want to see if simple geriatric screening tests can predict who will have side effects or a drop in quality of life. …
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Sponsor: Region Jönköping County • Aim: Knowledge-focused
Last updated May 26, 2026 04:22 UTC
-
Scientists to spy on cancer cells during treatment to predict who will respond
Knowledge-focused Not yet recruitingThis study looks at tumor samples from 55 women with early-stage breast cancer (triple-negative or high-risk luminal) before, during, and after standard chemo-immunotherapy. Using single-cell RNA sequencing and imaging, researchers aim to identify early signs of treatment respons…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: NA • Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated May 26, 2026 04:15 UTC